[Entecavir therapy against hepatitis B].
Kato
Naoya
N
Department of Gastroenterology, Graduate School of Medicine, University of Tokyo.
Omata
Masao
M
D000818:Animals; D000998:Antiviral Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D024882:Drug Resistance, Viral; D006147:Guanine / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D006515:Hepatitis B virus / Q000187:drug effects / Q000201:enzymology / Q000502:physiology; D019694:Hepatitis B, Chronic / Q000188:drug therapy* / Q000821:virology; D006801:Humans; D019384:Nucleic Acid Synthesis Inhibitors; D016896:Treatment Outcome; D014779:Virus Replication / Q000187:drug effects
D000998:Antiviral Agents; D019384:Nucleic Acid Synthesis Inhibitors; C413685:entecavir; D006147:Guanine